ARTICLE | Company News
Medarex, Merck KGaA deal
January 4, 1999 8:00 AM UTC
Merck obtained an exclusive option to negotiate for worldwide licensing rights outside the U.S. to the partners' jointly developed bispecific antibody MDX-447. Currently, Merck has marketing rights in...